iBeta

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO says can "understand the concept of time and how you change, from cradle to grave.

InterContinental Beverage Capital held its Annual Partners Meeting reflecting on 2024's industry trends and outlining its 2025 strategy. Key insights included the rise of functional beverages, AI's impact,

Passive Brain-Computer Interfaces (pBCIs) have shown significant advancements in recent years, indicating their readiness for practical, everyday

Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million grant from the European Innovation Council (EIC) Accelerator to advance its AI and robotics synthesis automation technology.

Biotechnology innovations are revolutionizing healthcare with AI, data science, and automation, leading to more precise and personalized treatments.

Women's healthcare has long been underserved when it comes to technological innovation. While advancements in digital health have transformed diagnostics, disease management, and personalized medicine,